TGF-β-target genes have been comprehensively identified in many kinds of tumors, including liver cancer, pancreatic cancer, NSCLC and breast cancer [17, 36–38], but rarely in neuroendocrine tumors. This evidence concerns the gene TGFB1 and pancreatic neoplasm.